Labcorp Holdings Inc.
LHFigures shown here come from public SEC filings. Dates beside each section show the available history.
How Labcorp Holdings Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 19 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated Jun 10, 2026.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Labcorp Holdings Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-03-03 · Schechter Adam H: Larger than all 26 other insider sales of Common Stock on file. SEC filing
- 2025-10-31 · Parham Richelle P: Larger than 25 of the 26 other insider sales of Common Stock on file. SEC filing
- 2025-05-12 · Schechter Adam H: Larger than 24 of the 26 other insider sales of Common Stock on file. SEC filing
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-06-08 | Kyle Kathryn W · EVP, Chief Legal Officer | Common Stock | S — Open market or private sale | −762 | 263.89 | SEC filing |
| 2026-05-11 | Schechter Adam H · President & CEO | Common Stock | S — Open market or private sale | −5,903 | 254.50 | SEC filing |
| 2026-03-27 | Meltzer Jonathan C · EVP, Operations | Common Stock | S — Open market or private sale | −839 | 267.05 | SEC filing |
| 2026-03-27 | Wilkinson Peter J · SVP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −1,633 | 267.05 | SEC filing |
| 2026-03-03 | Schechter Adam H · President & CEO | Common Stock | S — Open market or private sale | −8,705 | 279.96 | SEC filing |
| 2026-02-27 | van der Vaart Sandra D · EVP, Corporate Affairs | Common Stock | S — Open market or private sale | −548 | 284.91 | SEC filing |
| 2026-02-24 | Caveney Brian J · EVP, Pres of ED, CMO & CSO | Common Stock | S — Open market or private sale | −1,500 | 286.31 | SEC filing |
| 2026-02-19 | Wilkinson Peter J · SVP, Chief Accounting Officer | Common Stock | S — Open market or private sale | −666 | 277.94 | SEC filing |
Showing 8 of 10 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-26 | Bailey Megan D. · EVP, Pres, Central Labs & Intl | Common Stock | A — Grant, award, or other acquisition | +1,184 | SEC filing |
| 2026-03-26 | GRAHAM ANITA Z · EVP, CHRO | Common Stock | A — Grant, award, or other acquisition | +6,604 | SEC filing |
| 2026-03-26 | Wilkinson Peter J · SVP, Chief Accounting Officer | Common Stock | A — Grant, award, or other acquisition | +2,388 | SEC filing |
| 2026-03-26 | Summy Amy B. · EVP, Chief Marketing Officer | Common Stock | A — Grant, award, or other acquisition | +3,994 | SEC filing |
| 2026-03-26 | Schroeder Mark S · EVP, Pres Diagnostics & COO | Common Stock | A — Grant, award, or other acquisition | +2,968 | SEC filing |
| 2026-03-26 | van der Vaart Sandra D · EVP, Corporate Affairs | Common Stock | A — Grant, award, or other acquisition | +6,382 | SEC filing |
| 2026-03-26 | Caveney Brian J · EVP, Pres of ED, CMO & CSO | Common Stock | A — Grant, award, or other acquisition | +9,304 | SEC filing |
| 2026-03-26 | Meltzer Jonathan C · EVP, Operations | Common Stock | A — Grant, award, or other acquisition | +2,388 | SEC filing |
Showing 8 of 30 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.